vs

Side-by-side financial comparison of Broadway Financial Corp (BYFC) and Fortress Biotech, Inc. (FBIO). Click either name above to swap in a different company.

Fortress Biotech, Inc. is the larger business by last-quarter revenue ($16.1M vs $9.4M, roughly 1.7× Broadway Financial Corp). Broadway Financial Corp runs the higher net margin — 1934.0% vs -24.5%, a 1958.5% gap on every dollar of revenue. On growth, Broadway Financial Corp posted the faster year-over-year revenue change (10.1% vs 6.3%). Over the past eight quarters, Fortress Biotech, Inc.'s revenue compounded faster (11.0% CAGR vs 9.7%).

Virtu Financial, Inc. is an American high-frequency trading company. The company went public on the Nasdaq in 2015.

Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida.

BYFC vs FBIO — Head-to-Head

Bigger by revenue
FBIO
FBIO
1.7× larger
FBIO
$16.1M
$9.4M
BYFC
Growing faster (revenue YoY)
BYFC
BYFC
+3.8% gap
BYFC
10.1%
6.3%
FBIO
Higher net margin
BYFC
BYFC
1958.5% more per $
BYFC
1934.0%
-24.5%
FBIO
Faster 2-yr revenue CAGR
FBIO
FBIO
Annualised
FBIO
11.0%
9.7%
BYFC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BYFC
BYFC
FBIO
FBIO
Revenue
$9.4M
$16.1M
Net Profit
$1.0M
$-3.9M
Gross Margin
66.1%
Operating Margin
-28.8%
Net Margin
1934.0%
-24.5%
Revenue YoY
10.1%
6.3%
Net Profit YoY
-21.8%
41.8%
EPS (diluted)
$0.02
$-0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BYFC
BYFC
FBIO
FBIO
Q4 25
$9.4M
$16.1M
Q3 25
$9.0M
$17.6M
Q2 25
$8.1M
$16.4M
Q1 25
$8.3M
$13.1M
Q4 24
$8.6M
$15.1M
Q3 24
$8.7M
$14.6M
Q2 24
$8.2M
$14.9M
Q1 24
$7.8M
$13.0M
Net Profit
BYFC
BYFC
FBIO
FBIO
Q4 25
$1.0M
$-3.9M
Q3 25
$-23.9M
$5.8M
Q2 25
$752.0K
$15.5M
Q1 25
$-2.7M
$-10.6M
Q4 24
$1.3M
$-6.8M
Q3 24
$516.0K
$-12.9M
Q2 24
$256.0K
$-10.9M
Q1 24
$-154.0K
$-15.4M
Gross Margin
BYFC
BYFC
FBIO
FBIO
Q4 25
66.1%
Q3 25
67.4%
Q2 25
69.9%
Q1 25
63.5%
Q4 24
69.1%
Q3 24
69.4%
Q2 24
61.6%
Q1 24
53.9%
Operating Margin
BYFC
BYFC
FBIO
FBIO
Q4 25
-28.8%
Q3 25
-256.2%
-38.6%
Q2 25
12.8%
-222.2%
Q1 25
-45.3%
-169.9%
Q4 24
21.7%
-158.3%
Q3 24
8.5%
-151.0%
Q2 24
4.8%
-186.5%
Q1 24
-2.9%
-280.6%
Net Margin
BYFC
BYFC
FBIO
FBIO
Q4 25
1934.0%
-24.5%
Q3 25
-264.2%
33.2%
Q2 25
9.3%
94.4%
Q1 25
-32.3%
-80.6%
Q4 24
15.3%
-44.7%
Q3 24
5.9%
-88.0%
Q2 24
3.1%
-73.5%
Q1 24
-2.0%
-118.3%
EPS (diluted)
BYFC
BYFC
FBIO
FBIO
Q4 25
$0.02
$-0.15
Q3 25
$-2.86
$0.11
Q2 25
$0.00
$0.45
Q1 25
$-0.39
$-0.48
Q4 24
$0.07
$-0.16
Q3 24
$-0.03
$-0.76
Q2 24
$0.02
$-0.73
Q1 24
$-0.02
$-1.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BYFC
BYFC
FBIO
FBIO
Cash + ST InvestmentsLiquidity on hand
$10.5M
$79.4M
Total DebtLower is stronger
$52.4M
Stockholders' EquityBook value
$262.8M
$49.9M
Total Assets
$1.3B
$185.5M
Debt / EquityLower = less leverage
1.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BYFC
BYFC
FBIO
FBIO
Q4 25
$10.5M
$79.4M
Q3 25
$19.7M
$86.2M
Q2 25
$29.5M
$74.4M
Q1 25
$15.8M
$91.3M
Q4 24
$61.4M
$57.3M
Q3 24
$97.1M
$58.9M
Q2 24
$89.8M
$76.2M
Q1 24
$67.1M
$83.8M
Total Debt
BYFC
BYFC
FBIO
FBIO
Q4 25
$52.4M
Q3 25
$47.8M
Q2 25
$50.0M
Q1 25
$56.4M
Q4 24
$58.0M
Q3 24
$52.5M
Q2 24
$67.0M
Q1 24
$61.4M
Stockholders' Equity
BYFC
BYFC
FBIO
FBIO
Q4 25
$262.8M
$49.9M
Q3 25
$261.7M
$55.9M
Q2 25
$284.7M
$43.9M
Q1 25
$283.6M
$22.3M
Q4 24
$285.0M
$22.7M
Q3 24
$286.2M
$21.2M
Q2 24
$282.1M
$17.9M
Q1 24
$281.1M
$23.0M
Total Assets
BYFC
BYFC
FBIO
FBIO
Q4 25
$1.3B
$185.5M
Q3 25
$1.3B
$181.4M
Q2 25
$1.2B
$159.9M
Q1 25
$1.3B
$178.1M
Q4 24
$1.3B
$144.2M
Q3 24
$1.4B
$127.1M
Q2 24
$1.4B
$145.7M
Q1 24
$1.4B
$164.6M
Debt / Equity
BYFC
BYFC
FBIO
FBIO
Q4 25
1.05×
Q3 25
0.86×
Q2 25
1.14×
Q1 25
2.53×
Q4 24
2.55×
Q3 24
2.48×
Q2 24
3.75×
Q1 24
2.67×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BYFC
BYFC
FBIO
FBIO
Operating Cash FlowLast quarter
$230.0K
$-12.5M
Free Cash FlowOCF − Capex
$-13.0K
FCF MarginFCF / Revenue
-0.1%
Capex IntensityCapex / Revenue
2.6%
Cash ConversionOCF / Net Profit
0.22×
TTM Free Cash FlowTrailing 4 quarters
$2.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BYFC
BYFC
FBIO
FBIO
Q4 25
$230.0K
$-12.5M
Q3 25
$3.8M
$-6.1M
Q2 25
$3.0M
$-27.6M
Q1 25
$-4.3M
$-19.6M
Q4 24
$1.4M
$-12.9M
Q3 24
$6.1M
$-20.1M
Q2 24
$9.8M
$-21.8M
Q1 24
$-11.7M
$-25.4M
Free Cash Flow
BYFC
BYFC
FBIO
FBIO
Q4 25
$-13.0K
Q3 25
$3.7M
Q2 25
$3.0M
Q1 25
$-4.4M
Q4 24
$1.3M
Q3 24
$6.1M
Q2 24
$9.7M
Q1 24
$-11.7M
FCF Margin
BYFC
BYFC
FBIO
FBIO
Q4 25
-0.1%
Q3 25
41.1%
Q2 25
37.0%
Q1 25
-52.4%
Q4 24
14.7%
Q3 24
69.6%
Q2 24
118.9%
Q1 24
-149.7%
Capex Intensity
BYFC
BYFC
FBIO
FBIO
Q4 25
2.6%
Q3 25
1.2%
Q2 25
0.2%
Q1 25
0.2%
Q4 24
1.6%
Q3 24
0.3%
0.0%
Q2 24
0.5%
Q1 24
0.7%
Cash Conversion
BYFC
BYFC
FBIO
FBIO
Q4 25
0.22×
Q3 25
-1.04×
Q2 25
4.00×
-1.78×
Q1 25
Q4 24
1.06×
Q3 24
11.85×
Q2 24
38.21×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons